Test Catalog

Test ID: F9KMP    
Hemophilia B, F9 Gene Known Mutation Analysis, Prenatal

Method Description Describes how the test is performed and provides a method-specific reference

Direct mutation analysis of leukocyte genomic DNA performed by PCR amplification of a single region of the F9 gene, followed by fluorescent DNA sequencing analysis utilizing an Applied Biosystems Inc. (ABI) 3730xl DNA Analyzer.(Costa JM, Ernault P, Vidaud D, et al: Fast and efficient mutation detection method using multiplex PCR and cycle sequencing-application to haemophilia B. Thromb Haemost 2000;83[2]:244-247; Kaiser RJ, MacKellar SL, Vinayak RS, et al: Specific-primer-directed DNA sequencing using automated fluorescence detection. Nucleic Acids Res 1989;17[15]:6087-6102)

PDF Report Indicates whether the report includes an additional document with charts, images or other enriched information


Day(s) Performed Outlines the days the test is performed. This field reflects the day that the sample must be in the testing laboratory to begin the testing process and includes any specimen preparation and processing time before the test is performed. Some tests are listed as continuously performed, which means that assays are performed multiple times during the day.

Monday through Friday

Report Available The interval of time (receipt of sample at Mayo Clinic Laboratories to results available) taking into account standard setup days and weekends. The first day is the time that it typically takes for a result to be available. The last day is the time it might take, accounting for any necessary repeated testing.

28 to 35 days

Specimen Retention Time Outlines the length of time after testing that a specimen is kept in the laboratory before it is discarded

Extracted DNA indefinitely, patient must opt-out.

Performing Laboratory Location Indicates the location of the laboratory that performs the test